Form preview

Get the free Genentech, Inc. - Form 8-K (Period ended January 10, 2006) - SEC - sec

Get Form
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of the earliest
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign

Edit
Edit your genentech inc - form form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your genentech inc - form form via URL. You can also download, print, or export forms to your preferred cloud storage service.

Editing genentech inc - form online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
To use the professional PDF editor, follow these steps below:
1
Log into your account. It's time to start your free trial.
2
Upload a file. Select Add New on your Dashboard and upload a file from your device or import it from the cloud, online, or internal mail. Then click Edit.
3
Edit genentech inc - form. Rearrange and rotate pages, add and edit text, and use additional tools. To save changes and return to your Dashboard, click Done. The Documents tab allows you to merge, divide, lock, or unlock files.
4
Save your file. Select it from your records list. Then, click the right toolbar and select one of the various exporting options: save in numerous formats, download as PDF, email, or cloud.
With pdfFiller, it's always easy to work with documents.
Yes x No o The information required by this amendment is included in Genetic, Inc.'s current report on Form 8-K filed with the Securities and Exchange Commission on January 10, 2006. (Added by Statute Amendment No. 748, filed December 21, 2002.) COMMISSION ACTIVITY CHECK MARK The registrant's filing status is kept on file with the Commission pursuant to Rule 405 of the Securities Act of 1933, as amended. Genetic, Inc. Form 8-K / 7 86-2347624 January 10, 2006 1. DESCRIPTION OF BUSINESS The Company develops and licenses DNA testing and analysis solutions to the scientific community. The DNA testing solutions provide evidence of ancestry, ancestry relatedness and relatedness to people who possess a particular unique human DNA sequence or DNA fragment. The Company is filed under Chapter 15 of the Code. DNA Technologies. Genetic Laboratories, Inc. Genetic Laboratories, Inc., through its subsidiaries, is engaged in the commercial development of technologies designed for the direct analysis of DNA. DNA solutions include tests for ancestry, ancestry relatedness, and relatedness. The Company's DNA testing solutions are designed to address DNA related concerns of customers, clients, and other DNA related entities.

Fill form : Try Risk Free

Rate free

4.0
Satisfied
54 Votes

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

Genentech Inc - Form is a form that is required by the Securities and Exchange Commission (SEC) for publicly traded companies to report their financial and operational information.
Genentech Inc - Form is required to be filed by Genentech Inc, which is a publicly traded company.
Genentech Inc - Form can be filled out by obtaining the form from the SEC's website and providing all the necessary financial and operational information as required by the form.
The purpose of Genentech Inc - Form is to provide transparency and accountability of Genentech Inc's financial and operational information to the public and investors.
Genentech Inc - Form requires reporting of financial statements, executive compensation, significant business events, and other pertinent information related to the company's financial and operational performance.
The deadline to file Genentech Inc - Form in 2023 is typically 60 days after the end of Genentech Inc's fiscal year, which is usually December 31st.
The penalty for late filing of Genentech Inc - Form can vary, but it may include fines imposed by the SEC and potential legal consequences for non-compliance.
Filling out and eSigning genentech inc - form is now simple. The solution allows you to change and reorganize PDF text, add fillable fields, and eSign the document. Start a free trial of pdfFiller, the best document editing solution.
You can. With pdfFiller, you get a strong e-signature solution built right into your Chrome browser. Using our addon, you may produce a legally enforceable eSignature by typing, sketching, or photographing it. Choose your preferred method and eSign in minutes.
The pdfFiller mobile applications for iOS and Android are the easiest way to edit documents on the go. You may get them from the Apple Store and Google Play. More info about the applications here. Install and log in to edit genentech inc - form.

Fill out your genentech inc - form online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview

Related Forms